Insertion of type O-conserved neutralizing epitope into the foot-and-mouth disease virus type Asia1 VP1 G-H loop: effect on viral replication and neutralization phenotype

被引:14
作者
Wang, Haiwei [1 ,2 ]
Xue, Mei [1 ]
Yang, Decheng [1 ]
Zhou, Guohui [1 ]
Wu, Donglai [1 ,2 ]
Yu, Li [1 ]
机构
[1] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Livestock Infect Dis, Harbin 150001, Peoples R China
[2] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Key Lab Vet Publ Hlth,Minist Agr, Harbin 150001, Peoples R China
关键词
MAJOR ANTIGENIC SITE; IMMUNODEFICIENCY-VIRUS; MONOCLONAL-ANTIBODY; CAPSID PROTEIN; INTEGRIN ALPHA(V)BETA(3); PROTECTIVE IMMUNITY; VACCINE; RECEPTOR; BINDING; CATTLE;
D O I
10.1099/vir.0.040253-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Previously, we finely mapped the neutralizing epitopes recognized by foot-and-mouth disease virus (FMDV) type Asial-specific mAb 3E11 and FMDV type O-specific mAb 8E8. In this study, we engineered recombinant FMDVs of the serotype Asia1 (rFMDVs) displaying the type O-neutralizing epitope recognized by the mAb 8E8. These epitope-inserted viruses were genetically stable and exhibited growth properties that were similar to those of their parental virus. Importantly, the recombinant virus rFMDV-C showed neutralization sensitivity to both FMDV type Asia1 and type O mAbs, as well as to polyclonal antibodies. These results indicated that this epitope-inserted virus has the potential to induce neutralizing antibodies against both FMDV type Asial and type O. Our results demonstrated that the G-H loop of FMDV type Asial effectively displays the protective neutralizing epitopes of other FMDV serotypes, making this an attractive approach for the design of novel FMDV vaccines.
引用
收藏
页码:1442 / 1448
页数:7
相关论文
共 40 条
[1]   THE 3-DIMENSIONAL STRUCTURE OF FOOT-AND-MOUTH-DISEASE VIRUS AT 2.9-A RESOLUTION [J].
ACHARYA, R ;
FRY, E ;
STUART, D ;
FOX, G ;
ROWLANDS, D ;
BROWN, F .
NATURE, 1989, 337 (6209) :709-716
[2]   ANTIBODIES TO THE VITRONECTIN RECEPTOR (INTEGRIN ALPHA(V)BETA(3)) INHIBIT BINDING AND INFECTION OF FOOT-AND-MOUTH-DISEASE VIRUS TO CULTURED-CELLS [J].
BERINSTEIN, A ;
ROIVAINEN, M ;
HOVI, T ;
MASON, PW ;
BAXT, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2664-2666
[3]   PROTECTION AGAINST FOOT-AND-MOUTH-DISEASE BY IMMUNIZATION WITH A CHEMICALLY SYNTHESIZED PEPTIDE PREDICTED FROM THE VIRAL NUCLEOTIDE-SEQUENCE [J].
BITTLE, JL ;
HOUGHTEN, RA ;
ALEXANDER, H ;
SHINNICK, TM ;
SUTCLIFFE, JG ;
LERNER, RA ;
ROWLANDS, DJ ;
BROWN, F .
NATURE, 1982, 298 (5869) :30-33
[4]   A HIGHLY DIVERGENT ANTIGENIC SITE OF FOOT-AND-MOUTH-DISEASE VIRUS RETAINS ITS IMMUNODOMINANCE [J].
BORREGO, B ;
CAMARERO, JA ;
MATEU, MG ;
DOMINGO, E .
VIRAL IMMUNOLOGY, 1995, 8 (01) :11-18
[5]   IMPROVED IMMUNOGENICITY OF A PEPTIDE EPITOPE AFTER FUSION TO HEPATITIS-B CORE PROTEIN [J].
CLARKE, BE ;
NEWTON, SE ;
CARROLL, AR ;
FRANCIS, MJ ;
APPLEYARD, G ;
SYRED, AD ;
HIGHFIELD, PE ;
ROWLANDS, DJ ;
BROWN, F .
NATURE, 1987, 330 (6146) :381-384
[6]   Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients:: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine [J].
Dorrell, L ;
Yang, HB ;
Iversen, AKN ;
Conlon, C ;
Suttill, A ;
Lancaster, M ;
Dong, T ;
Cebere, I ;
Edwards, A ;
Rowland-Jones, S ;
Hanke, T ;
McMichael, AJ .
AIDS, 2005, 19 (12) :1321-1323
[7]   AN ENGINEERED POLIOVIRUS CHIMERA ELICITS BROADLY REACTIVE HIV-1 NEUTRALIZING ANTIBODIES [J].
EVANS, DJ ;
MCKEATING, J ;
MEREDITH, JM ;
BURKE, KL ;
KATRAK, K ;
JOHN, A ;
FERGUSON, M ;
MINOR, PD ;
WEISS, RA ;
ALMOND, JW .
NATURE, 1989, 339 (6223) :385-388
[8]   Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge [J].
Fischer, D ;
Rood, D ;
Barrette, RW ;
Zuwallack, A ;
Kramer, E ;
Brown, F ;
Silbart, LK .
JOURNAL OF VIROLOGY, 2003, 77 (13) :7486-7491
[9]   Foot-and-mouth disease marker vaccine: Cattle protection with a partial VP1 G-H loop deleted virus antigen [J].
Fowler, V. L. ;
Bashiruddin, J. B. ;
Maree, F. F. ;
Mutowembwa, P. ;
Bankowski, B. ;
Gibson, D. ;
Cox, S. ;
Knowles, N. ;
Barnett, P. V. .
VACCINE, 2011, 29 (46) :8405-8411
[10]   Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion [J].
Fowler, V. L. ;
Knowles, N. J. ;
Paton, D. J. ;
Barnett, P. V. .
VACCINE, 2010, 28 (19) :3428-3434